These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3554798)

  • 41. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Abortion induction in disordered pregnancy in the 1st and 2d trimester by local and systemic administration of sulprostone].
    Tabarelli M; Heim K; Mayr P; Karpellus E
    Gynakol Rundsch; 1988; 28 Suppl 2():221-4. PubMed ID: 3234920
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prostaglandins and the uterine cervix. Immunofluorescence study].
    Compan C; Laffargue F; Pages A; Pages AM; Déparzia P
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(4):451-4. PubMed ID: 2674268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
    J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). SFP Guideline 20071.
    Allen RH; Goldberg AB;
    Contraception; 2007 Aug; 76(2):139-56. PubMed ID: 17656184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of oral and vaginal misoprostol for cervical ripening before evacuation of first trimester missed miscarriage.
    Jabir M; Smeet RI
    Saudi Med J; 2009 Jan; 30(1):82-7. PubMed ID: 19139779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of sulprostone for voluntary interruption of gestation and in intrauterine fetal death].
    Di Meglio L; Malagnino F; Ballerini M; Mocchia M
    Minerva Ginecol; 1990 Mar; 42(3):75-8. PubMed ID: 2338963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandin E2-induced ripening of the human cervix involves changes in proteoglycan metabolism.
    Norman M; Ekman G; Malmström A
    Obstet Gynecol; 1993 Dec; 82(6):1013-20. PubMed ID: 8233252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biochemical principles of cervix ripening and dilatation].
    Rath W; Osmers R; Stuhlsatz HW; Adelmann-Grill BC
    Z Geburtshilfe Perinatol; 1994; 198(5-6):186-95. PubMed ID: 7717006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cervical maturation and induction of labor with PgE2 gel. Authors' experience].
    Carta G; Vigilante M; Di Cesare S; Mascaretti G; Caserta D; Moscarini M
    Minerva Ginecol; 1997 Oct; 49(10):427-32. PubMed ID: 9463175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in collagen content of the first trimester cervix uteri after treatment with prostaglandin F2 alpha gel.
    Rath W; Theobald P; Kühnle H; Kuhn W; Hilgers H; Weber L
    Arch Gynecol; 1982; 231(2):107-10. PubMed ID: 7073332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The physiology of cervical ripening and cervical dilatation and the effect of abortifacient drugs.
    Uldbjerg N; Ulmsten U
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):263-82. PubMed ID: 2225599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Collagenase activity in the human cervix uteri after prostaglandin E2 application during the first trimester.
    Osmers R; Rath W; Adelmann-Grill BC; Fittkow C; Szeverényi M; Kuhn W
    Eur J Obstet Gynecol Reprod Biol; 1991 Nov; 42(1):29-32. PubMed ID: 1663873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of prostaglandins on the lysosomal function in the cervix uteri.
    Joh K; Riede UN; Zahradnik HP
    Arch Gynecol; 1983; 234(1):1-16. PubMed ID: 6660924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tonometric studies on the pregnant cervix uteri in abortion before and after intracervical administration of prostaglandin F2 gel].
    Rath W; Theobald P; Ulbrich R; Grande P; Kühnle H
    Arch Gynecol; 1979 Jul; 228(1-4):416-7. PubMed ID: 485404
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of prostaglandin D2 on the biosynthesis of connective tissue constituents in the pregnant human cervix.
    Norström A
    Prostaglandins; 1982 Mar; 23(3):361-7. PubMed ID: 6954573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical changes in human cervical connective tissue after local application of prostaglandin E2.
    Uldbjerg N; Ekman G; Malmström A; Ulmsten U; Wingerup L
    Gynecol Obstet Invest; 1983; 15(5):291-9. PubMed ID: 6303918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collagenase activity in the cervix of non-pregnant and pregnant women.
    Osmers R; Rath W; Adelmann-Grill BC; Fittkow C; Severényi M; Kuhn W
    Arch Gynecol Obstet; 1990; 248(2):75-80. PubMed ID: 1964036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ripening of the cervix with sodium nitroprusside in nonpregnant women.
    Piccinini F; Fano RA; Volpe A; Facchinetti F
    J Soc Gynecol Investig; 2003 Oct; 10(7):438-42. PubMed ID: 14519486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.